SCHEMBL25682952

SCHEMBL25682952

CCCc1cccc2c3ccc4oc5ccccc5c4c3n(C)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.35
▸ TP53 P04637 4/20 0.35
▸ MAPT P10636 3/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ LMNA P02545 4/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ HPGD P15428 3/20 0.35
▸ HTT P42858 1/20 0.35
▸ ALKBH5 Q6P6C2 2/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ RAB9A P51151 2/20 0.33
▸ CYP17A1 P05093 1/20 0.33
▸ CYP19A1 P11511 1/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ FTO Q9C0B1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25682955 0.86 ALKBH5 (0.36) SMN1; SMN2TP53MAPTALDH1A1LMNA
SCHEMBL25997645 0.84 ALKBH5 (0.35) SMN1; SMN2TP53MAPTALDH1A1LMNA
SCHEMBL25678296 0.84 MAOA (0.42) SMN1; SMN2MAPTALDH1A1LMNAKDM4E
SCHEMBL25683366 0.83 ALKBH5 (0.44) SMN1; SMN2TP53MAPTALDH1A1LMNA
SCHEMBL8521819 0.79 MAOA (0.41) SMN1; SMN2MAPTALDH1A1KDM4EHPGD
SCHEMBL25682993 0.79 ALKBH5 (0.43) SMN1; SMN2MAPTALDH1A1LMNAKDM4E
SCHEMBL25682129 0.79 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1LMNAKDM4EHPGD
SCHEMBL13183680 0.78 ALKBH5 (0.50) SMN1; SMN2MAPTALDH1A1LMNAKDM4E
SCHEMBL25682953 0.78 HPGD (0.41) SMN1; SMN2TP53MAPTALDH1A1LMNA
SCHEMBL25683061 0.78 CYP1A2 (0.38) SMN1; SMN2TP53MAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
EP-4190791-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT Kyulux, Inc. (JP) 2023-06-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CCNE2, CRY2 SMN1; SMN2 3623/4885TP53 3892/4885MAPT 1225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback